AR and neoplasm: This occurs due to the development of resistance mechanisms, including amplification or mutation of the androgen receptor (AR) gene (Ruizeveld de Winter et al., 1994; Taplin et al., 2003), increased expression of AR splice variants (Sun et al., 2010), and activation of alternative signaling pathways that regulate tumor growth independently of androgens.